Thieme E-Books & E-Journals -
Zurück
Pneumologie 2023; 77(S 01): S58-S59
DOI: 10.1055/s-0043-1761006
Abstracts

Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England

G Requena
1   Gsk, R&d Global Medical, Brentford, Middlesex, UK
,
A Czira
1   Gsk, R&d Global Medical, Brentford, Middlesex, UK
,
V Banks
2   Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK
,
R Wood
2   Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK
,
T Tritton
2   Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK
,
C Castillo
2   Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK
,
J Yeap
2   Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK
,
R Wild
2   Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK
,
C Compton
1   Gsk, R&d Global Medical, Brentford, Middlesex, UK
,
M Duarte
1   Gsk, R&d Global Medical, Brentford, Middlesex, UK
,
K Rothnie
1   Gsk, R&d Global Medical, Brentford, Middlesex, UK
,
F Herth
3   University Hospital Heidelberg; Institute of Internal Medicin III – Pneumology; Thoraxklinik
,
A Ismaila
4   Value Evidence and Outcomes, Glaxosmithkline, Collegeville, Pa, Usa; Department of Health Research Methods, Evidence and Impact, Mcmaster University, Hamilton, ON, Canada
› Institutsangaben